Wells Fargo
TRPX

Wells Fargo’s Therapix Biosciences Ltd. TRPX Stock Holding History

Wells Fargo’s Portfolio TRPX Stock Details TRPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-500
Closed – – 7334
2020
Q2 		$0 Hold
500
– – ﹤0.01% 7182
2020
Q1 		$0 Hold
500
– – ﹤0.01% 7197
2019
Q4 		$1K Hold
500
– – ﹤0.01% 6306
2019
Q3 		$1K Buy
+500
New +$1.26K ﹤0.01% 6331

Wells Fargo's TRPX Position: Q3 2020 in Review

Wells Fargo sold out of Therapix Biosciences Ltd. (TRPX) in Q3 2020, closing a stake of 500 shares.

Wells Fargo first reported a position in TRPX in Q3 2019 and held it in 4 quarters. The position peaked at $1K in Q4 2019. 0 funds tracked by Wall St. Rank hold TRPX as of Q3 2020.

  • Wells Fargo reported no remaining Therapix Biosciences Ltd. position as of Q3 2020 after selling out during the quarter.
  • Wells Fargo sold 500 Therapix Biosciences Ltd. shares in Q3 2020.
  • Wells Fargo first reported a position in Therapix Biosciences Ltd. in Q3 2019 and held it in 4 quarters.
  • Wells Fargo's Therapix Biosciences Ltd. position peaked at $1K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Therapix Biosciences Ltd. as of Q3 2020.

Based on Wells Fargo's 13F filing for Q3 2020, filed 5 Nov 2020.